Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures (CARDIF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01370044
Recruitment Status : Terminated (results of interim analysis (not safety relevant))
First Posted : June 9, 2011
Last Update Posted : January 26, 2018
Information provided by (Responsible Party):
Markus Schuelke, M.D., Charite University, Berlin, Germany